Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Deltex Medical Group Opens New US Account

3rd Sep 2014 06:46

LONDON (Alliance News) - Deltex Medical Group PLC said Wednesday that it has opened a new account in the USA following a successful clinical evaluation.

The company, which manufactures and markets Oesophageal Doppler Monitoring systems, said the new account is with a major teaching hospital in south-east USA. The hospital will be initially be introducing ODM into colorectal surgery, said Deltex.

Following the account win, the company said that it is creating a new sales territory to include this contract.

"We are pleased to be starting up a new sales territory with the most prestigious hospital in the region as our first implementation account. We will be working with the clinicians at the hospital in the coming months to further expand usage of ODM with the goal of making it a dedicated trainer account," said Chief Executive of Deltex Medical Ewan Phillips.

No financial terms of the account were disclosed.

Deltex's technology is used to measure blood flow during surgery by generating a low-frequency ultrasound signal utilising the Doppler effect. The Doppler effect, discovered by Austrian physicist Christian Doppler, is the change in frequency of a wave for an observer moving relative to its source, such as the way in which the noise of a siren changes when it passes by.

In July the company expressed growing confidence for the future due to increasing interest in its oesophageal Doppler monitoring products. Deltex said that its sales for the half-year to the end of June are expected to be around GBP3.0 million, slightly up from GBP2.9 million in the previous year.

US surgical probe sales rose 20% before foreign exchange differences in the half year, although UK surgical probe sales were down 13% due to National Health Service de-stocking. International sales of its surgical probes were up 11%.

The company plans to announce its results for the six months to June 30, 2014 on September 11, 2014.

By Alice Attwood; [email protected]; @AliceAtAlliance

Copyright 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

Deltex Medical
FTSE 100 Latest
Value8,809.74
Change53.53